Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy. - Wikidata - wikimedia - TriplyDB

Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.

Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.

http://www.wikidata.org/entity/Q33636262

about

Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography Multiple system atrophy: pathogenic mechanisms and biomarkers.Progressive supranuclear palsy: progression and survival.Vestibular Deficits in Neurodegenerative Disorders: Balance, Dizziness, and Spatial Disorientation.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.

P2860

Q26801152-333B0CF0-4B36-4DB5-8A3E-28501B87569C Q35926033-912D0185-908F-46A4-AC56-7CF1B0682E19 Q36314634-045348B7-7A71-41B4-A4A9-24DEEB7F1B37 Q38813304-A3743602-4138-4154-A39B-4A7D25E6F42E Q41020865-69C4E803-78AF-4855-909F-078A7299FF5E Q46132906-C9305B54-52A1-4359-8DAF-2FC6E988DEDA Q49562668-79D8AF48-4234-4516-BE55-E0C7D9C08F45

P2860

Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.

http://www.wikidata.org/entity/Q33636262

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Clinical features and disabili ...... rogressive supranuclear palsy.

@ast

Clinical features and disabili ...... rogressive supranuclear palsy.

@en

type

label

Clinical features and disabili ...... rogressive supranuclear palsy.

@ast

Clinical features and disabili ...... rogressive supranuclear palsy.

@en

prefLabel

Clinical features and disabili ...... rogressive supranuclear palsy.

@ast

Clinical features and disabili ...... rogressive supranuclear palsy.

@en

P1433

Q33636262-66CF0928-2519-4A6B-8409-C80D36F43500

P1476

Q33636262-46CA9ED8-1A8E-44AA-A721-1F7AC26C45A0

P2093

Q33636262-7E5F942F-FB7A-4C86-8393-B048FCB719B9

Q33636262-9FDACE56-3874-4957-BDD0-DD2996A21F9E

P2860

Q33636262-0A09A660-F900-4757-A360-F945F91CBD54

Q33636262-0E07B3CF-4AC8-44C0-998C-50E09A7905F7

Q33636262-103ACADF-3F16-48C7-B1DF-471BF4991614

Q33636262-143ACBCF-B353-4C79-A88C-CD6E046C037D

Q33636262-1668EE30-9D90-4485-A49B-AAAA032D6269

Q33636262-17E8B3F2-1540-41DE-9BF3-7999B118A40B

Q33636262-297A56D8-28F0-49E3-9503-43501E009A6C

Q33636262-497A26C9-5116-49D2-9FFE-743D31B7EDFF

Q33636262-5BCF84F8-7891-4B16-B441-46DC98B3CFA6

Q33636262-68A3A58D-8374-4F22-8DA3-07E4470319E3

P304

Q33636262-8A089CFE-CF43-4921-9CC7-252D1CBB7E4F

P31

Q33636262-96F3AA07-66DA-438C-BD71-2908C1BB0A88

P356

Q33636262-B0D43F8A-407B-4F55-8931-6612D2DE85DE

P433

Q33636262-0943EA06-89C6-4F85-94A1-E944DC85F26A

P478

Q33636262-52AE5577-5A4A-4A60-A714-9E88C89F8056

P577

Q33636262-D4D24952-2F08-4DAF-B34C-8EC01D5D6633

P5875

Q33636262-ECD8C01C-D540-4C17-8766-48689B59F7AC

P698

Q33636262-83CA47B0-0B6B-455E-A17D-1AD36BDB2FF7

P921

Q33636262-E3A5804F-0F9B-45EC-A282-2BF6A5C74793

P932

Q33636262-3A70925D-20E0-4350-B7DF-21D4C8084F47

P356

P1433

P1476

Clinical features and disabili ...... rogressive supranuclear palsy.

@en

P2093

Sang-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Seong-Beom Koh

http://www.w3.org/2001/XMLSchema#string

P2860

Second consensus statement on the diagnosis of multiple system atrophy

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.

Progressive supranuclear palsy: where are we now?

Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.

Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

P304

42-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14802/JMD.12010

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262680737

http://www.w3.org/2001/XMLSchema#string

P698

24868413

http://www.w3.org/2001/XMLSchema#string

P921

P932

4027659

http://www.w3.org/2001/XMLSchema#string